CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,952,385
- in 10 filings, $770K under 10b5-1 plans
Net −$3,952,385. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Saia John G. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +26,799 | 26,799 | ||
| 2025-03-12 | Saia John G. Chief Legal Officer | Grant or award · Restricted Stock Units | +17,866 | 17,866 | ||
| 2025-03-12 | Monroe Terilyn J. Chief People Officer | Grant or award · Stock Option (Right to Buy) | +24,363 | 24,363 | ||
| 2025-03-12 | Monroe Terilyn J. Chief People Officer | Grant or award · Restricted Stock Units | +16,242 | 16,242 | ||
| 2025-03-12 | Kalia Kumud Chief Information Officer | Grant or award · Stock Option (Right to Buy) | +24,363 | 24,363 | ||
| 2025-03-12 | Kalia Kumud Chief Information Officer | Grant or award · Restricted Stock Units | +16,242 | 16,242 | ||
| 2025-03-12 | Freeman Chris Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +23,145 | 23,145 | ||
| 2025-03-12 | Freeman Chris Chief Commercial Officer | Grant or award · Restricted Stock Units | +15,430 | 15,430 | ||
| 2025-03-12 | Eltoukhy Helmy Co-Chief Executive Officer | Grant or award · Restricted Stock Units | +19,258 | 19,258 | ||
| 2025-03-12 | Eltoukhy Helmy Co-Chief Executive Officer | Grant or award · Restricted Stock Units | +116,010 | 116,010 | ||
| 2025-03-12 | EAGLE CRAIG Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +24,363 | 24,363 | ||
| 2025-03-12 | EAGLE CRAIG Chief Medical Officer | Grant or award · Restricted Stock Units | +16,242 | 16,242 | ||
| 2025-03-12 | Chudova Darya Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +30,453 | 30,453 | ||
| 2025-03-12 | Chudova Darya Chief Technology Officer | Grant or award · Restricted Stock Units | +20,302 | 20,302 | ||
| 2025-03-12 | Bell Michael Brian Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,498 | 33,498 | ||
| 2025-03-12 | Bell Michael Brian Chief Financial Officer | Grant or award · Restricted Stock Units | +22,332 | 22,332 | ||
| 2025-03-04 | Joyce Meghan V. Director | Exercise or conversion 10b5-1 | +67 | 7,714 | ||
| 2025-03-04 | Joyce Meghan V. Director | Exercise or conversion · Restricted Stock Units 10b5-1 | −67 | 332 | ||
| 2025-03-03 | Joyce Meghan V. Director | Sale 10b5-1 | −100 | $42.71 | $4K | 7,647 |
| 2025-03-01 | Saia John G. Chief Legal Officer | Exercise or conversion | +5,686 | 40,387 |
Page 55 of 57 · 1,133 trades